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Background: Atrial fibrillation (AF) is a poor prognostic factor for cardiac procedures and surgery. There are limited data regarding the correlation 
between baseline AF on patients with severe aortic stenosis who undergo transcathater aortic valeve replacement (TAVR). We sought to investigate 
the short- and long-term effects of baseline AF in patients undergoing TAVR.
methods: Clinical data of patients with aortic stenosis who underwent TAVR were retrospectively analyzed. Patients were divided into two groups 
based on prevalence of either paroxysmal or chronic AF on baseline.
results: A total of 264 patients were included, 90 (34%) had AF at baseline and 174 (66%) did not have AF. There were no significant differences 
in baseline characteristics between AF and no-AF patients with 56% vs. 45% males; age was 84±7 vs. 84±7, STS score 11±5 vs. 11±4, hypertension 
98% vs. 91%, diabetes 27% vs. 33%, renal failure 63% vs. 57% and peripheral vascular disease 32% vs. 40%. In-hospital complications were more 
frequent among AF patients. One-year mortality was higher for AF patients. (Figure)
conclusions: AF patients have higher peri-procedural complications and poorer long-term outcomes. This population should be considered high 
risk and special measures to reduce complications should be employed.
